Disclosure. Dr. Maloney has no commercial relationship with MyDentist Turkey or any affiliated entity. She did not receive payment, travel, accommodation, equipment, or any other consideration in connection with this piece. The publication’s standing disclosures are at /disclosures/.
A note on disambiguation
This review is of the Turkish dental tourism operation at mydentistturkey.com, trading from Hacet Cad. No: 43/1, Alanya, Antalya Province. The publication notes specifically that this is not the UK domestic NHS-affiliated dental chain trading as “mydentist” or “{my}dentist” — that operation, MYDENTIST LIMITED (Companies House 05821987, incorporated 18 May 2006) and MYDENTIST GROUP LIMITED (Companies House 05657369, incorporated 19 December 2005), is headquartered at Europa House, Stoneclough Road, Kearsley, Manchester M26 1GG, and operates clinics across the UK under the NHS framework. The two operations are unrelated.
The risk of confusion between the two is itself relevant. A patient who searches “mydentist” and encounters the Turkish operation’s marketing alongside the UK NHS chain’s results may, without close attention, conflate the trustworthiness signal of the UK operation with the entirely separate Turkish operation.
What this review is and is not
This is a desk review. I have not visited MyDentist Turkey in Alanya. My evidence is: a Companies House search for UK corporate entities operating under the MyDentist Turkey name; the JCI Turkey directory at jointcommission.org; the Turkish Ministry of Health’s International Health Tourism Authorization Certificate framework documentation; the UK Parliamentary Hansard record on Turkish medical-tourism deaths (12 March 2024); the 2024 Royal College of Surgeons of England Bulletin on UK dentistry’s vulnerability to dental tourism; and the peer-reviewed literature on Turkish dental tourism complications.
The review applies the clinical-standards framework on the accountability and credential-verifiability axis. Categories 1 and 2 — clinical decision-making and procedure execution — are not directly assessable from publicly available evidence; the framework permits a desk-review FAIL where the absence of identifiable clinical operators and verifiable accreditations is itself the structural failure.
The corporate accountability finding
MyDentist Turkey, per its own publicly stated trading identity, operates as THM Health Services Construction Real Estate Tourism Import Export Industry and Trade Limited Company — a Turkish limited liability company headquartered in Alanya. The trading-entity name is broad in scope and crosses sectors that do not customarily share corporate structure (construction, real estate, tourism, import-export, industry, trade). The publication notes the breadth without drawing a conclusion from it; companies that operate across multiple sectors are common in some jurisdictions, and the breadth does not in itself indicate clinical-quality risk.
The accountability finding is what is not present:
No UK Companies House registration was surfaced for THM Health Services or for MyDentist Turkey under any spelling. A patient who books with MyDentist Turkey has no UK-incorporated corporate counterparty. Compared with the Dental Centre Turkey model — where a dissolved UK shell company existed and was the subject of an upheld ASA ruling — MyDentist Turkey’s structural position is even more attenuated.
No JCI accreditation was surfaced on the Joint Commission International Turkey directory at jointcommission.org/en/about-jci/jci-accredited-organizations/?c=Turkey. JCI accreditation is not a precondition of practising dentistry in Turkey, but is the international quality-system credential most commonly cited by tourism-focused clinics. Its absence is informative.
No ASA ruling against MyDentist Turkey was surfaced on the UK Advertising Standards Authority site. This absence does not establish compliance; it indicates that no UK-targeted advertising complaint has been formally upheld against the operation. Compared with the upheld ruling against Dental Centre Turkey UK Ltd (A22-1157178, November 2022), the difference may be one of marketing reach or compliance posture; the publicly available record does not allow distinction.
No named clinician with PubMed publications was identified through the research conducted for this review. The clinic’s own published material was not used as a credentialing source per the publication’s methodology.
The Turkish Ministry of Health’s International Health Tourism Authorization Certificate is the relevant mandatory licence for any Turkish clinic legally treating international patients (enacted via Official Gazette No. 30123, 13 July 2017). Whether MyDentist Turkey holds the certificate could not be confirmed from the publicly accessible Ministry sub-pages of shgmturizmdb.saglik.gov.tr reviewed for this piece — the directory’s structure does not permit direct search by clinic name. The publication does not assert MyDentist Turkey lacks the certificate; it notes that the Ministry’s directory is not publicly searchable in a way that lets a patient verify the certificate from outside Turkey through a single lookup.
The broader UK and Turkish regulatory context
Two pieces of publicly available evidence are relevant to any UK or Australian patient considering a Turkish dental tourism operation in 2026.
The UK Parliamentary Hansard record of 12 March 2024. A House of Commons debate titled Turkey: Surgical Procedures records that 28 British nationals died in Turkey following elective procedures between March 2019 and March 2024, per Foreign and Commonwealth Office figures cited in the debate. The figure relates to medical-tourism deaths broadly (not exclusively dental). The relevance to a dental review is structural: a tourism market in which 28 British nationals died across five years following elective procedures is a market with documented systemic patient-safety concerns, and the dental sector operates within the same regulatory environment.
The Royal College of Surgeons of England Bulletin 2024 (Volume 106, Issue 6). Multiple articles in the bulletin cover dental tourism. The article The vulnerability of UK dentistry to dental tourists and dental tourism (doi:10.1308/rcsbull.2024.107) characterises the marketing-driven international dental tourism business as making “a mockery of efforts to maintain standards and to protect consumers from unqualified and unregulated providers.” A companion article cites preliminary data suggesting that the majority of UK patients presenting with complications after overseas cosmetic surgery had their surgery in Turkey — a cosmetic-surgery figure that should not be conflated with a dental figure, but that documents the broader patient-safety pattern of the Turkish elective procedure market.
The 2025 Turkish health advertising regulation (Official Gazette No. 33075, 12 November 2025, Regulation on Promotional and Informative Activities in Health Services) prohibits patient testimonials, before/after retouching, surgical footage of patients, comparative claims, and influencer content. Enforcement against named dental tourism operators has not been reported in publicly accessible English-language sources at the date of this review — the regulation is approximately six months old as of this writing. A patient considering any Turkish dental tourism clinic should expect, over the coming year, increased regulatory scrutiny of the social-media and influencer content that has been a primary acquisition channel for the sector.
Category 1 — Clinical decision-making
Category 2 — Procedure execution
Category 3 — Sterilisation and infection control
Category 4 — Documentation and records
Category 5 — Post-treatment support and continuity of care
The British Dental Association’s survey data and the Royal College of Surgeons of England’s 2024 Bulletin coverage together document that the post-Turkish-treatment complication burden falls predominantly on the patient’s home health system. The NHS does not fund elective revision work for privately obtained overseas dental treatment. The Australian Dental Association’s Policy Statement 2.2.6 (approved 17 November 2023) explicitly recommends that “Australian residents should only seek elective dental treatment in Australia.”
What would change this finding
This is a desk review. The publicly available evidence is the basis for the FAIL. The evidence that would, in the publication’s structured judgement, change the finding to a CONCERN or a PASS includes:
- A current, verifiable Turkish Ministry of Health International Health Tourism Authorization Certificate, with a published certificate number that a patient can cross-reference with the Ministry’s registry.
- A current UK or other international corporate counterparty with documented liability coverage for international patients, registered on a publicly searchable registry.
- Named clinical staff with publicly verifiable credentials — Turkish specialist registration numbers (Diş Hekimliği Uzmanlık Sınavı / DUS), graduation records, and ideally peer-reviewed publication footprint.
- A published international-patient continuity protocol — named clinical contact, defined response time, domestic referral pathways by country, written warranty terms with jurisdiction.
- A documented infection-control protocol addressing the five questions in the dental sterilization standards long read, with audit documentation if available.
The publication does not make a clinical-execution finding against MyDentist Turkey. It makes a structural-accountability finding that the publicly available evidence is too thin to support an international-patient booking decision under the clinical-standards framework.
Overall finding
FAIL — verifiable accountability footprint is too thin to support an international-patient booking decision.
The four-filter framework for overseas dental treatment is the relevant patient-side tool. For MyDentist Turkey, Filters 3 and 4 fail on the public evidence: credential claims are not independently verifiable, and the continuity-of-care plan is not documented. The publication’s dental tourism trust gap long read documents why the patient cannot, from the information available to them, distinguish a defensible destination clinic from one with these gaps.
Re-review cadence: 12 months, or earlier on submission of evidence addressing each of the five gaps named under What would change this finding. Re-review at the publication’s expense; no fees are charged for any review, original or re-review.
For the same structural FAIL on the credential-verifiability axis, applied to a hair transplant operation co-marketing dentistry under the sub-brand “Vera Smile,” see the Vera Clinic Istanbul review. The two reviews differ in corporate structure detail but are the same framework outcome.